TheProfitWatch

BNTC - Benitec Biopharma Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.07 0.22 (1.68%) --- 0.0 (0.0%) 0.12 (0.91%) --- 0.22 (1.68%) --- ---

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.24
Diluted EPS:
-0.24
Basic P/E:
-55.375
Diluted P/E:
-55.375
RSI(14) 1m:
50.0
VWAP:
13.29
RVol:

Events

Period Kind Movement Occurred At

Related News